argenx SE (ARGX)

819.14 -27.13 (-3.21%) USD  |  NASDAQ  |  Oct 16, 16:00
819.04 -0.10 (-0.01%) After-Hours: 20:00
More

argenx Cash from Investing (Quarterly)

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2014 -0.0424M
Date Value
March 31, 2014 -0.0014M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 68.03M
Cellectis SA 18.75M
Akari Therapeutics Plc 0.00
Forte Biosciences, Inc. -147.84M
Halozyme Therapeutics, Inc. -62.66M

Cash from Investing (Quarterly) Related Metrics

Free Cash Flow 1.090B
Free Cash Flow Yield 2.04%